Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation

PHASE3CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

July 31, 1998

Study Completion Date

February 28, 2007

Conditions
Kidney Transplantation
Interventions
DRUG

Cyclosporin A: C0: 75-125ng/ml-dose adapted in the 3 groups

DRUG

Group A: CsA + Azathioprine(1 to 2 mg/kg/day)

DRUG

Group B: CsA + CellCept(500 mg x 2/day)

DRUG

Group C: CsAm

Trial Locations (5)

14033

Caen university Hospital, Caen

51092

Reims University Hospital, Reims

76031

Rouen University Hospital, Rouen

86021

Poitiers University hospital, Poitiers

87042

Dupuytren University Hospital, Limoges

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT00461825 - Maintenance Neoral Monotherapy Compared to Bitherapy in Renal Transplantation | Biotech Hunter | Biotech Hunter